Category: FDA Updates

FDA Updates

New FDA-Approved Therapy Brings At-Home Electrical Field Treatment to Pancreatic Cancer Care

The wearable system uses alternating electrical fields to disrupt cancer cell division and can be used continuously during daily activities.

FDA Updates

FDA Clears Elekta’s AI-Powered CT-Linear Accelerator

Elekta’s Evo system combines CT-guided radiation therapy with AI-enhanced imaging designed to support visualization of tumors and nearby organs at risk during treatment.

FDA Updates

FDA Issues Recall Early Alert for Olympus Single-Use Ligating Devices

Olympus has updated use instructions after reports that the ligation loop may not release as expected, potentially requiring emergency intervention.

Clearances

FDA Clears AI Tool for Coronary Plaque Analysis

The clearance enables on-premise AI analysis of coronary CT angiography for quantifying calcified and non-calcified plaque.

Recalls

NOxBOXi Delivery System Correction Issued After Reports of Nitric Oxide Dose Fluctuations

The FDA issued a safety alert after users reported nitric oxide dose fluctuations, potentially leading to hypoxemia or increased pulmonary artery pressure.

Labeling

Admetsys Blood Diagnostic System Made Breakthrough Device

Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.

Draft Guidances

FDA Proposes Ban on Electrical Stimulation Devices

The U.S. FDA has proposed banning electrical stimulation devices for self-injurious or aggressive behavior due to significant risks, marking the second attempt at prohibition, with implications including potential treatment transitions for users and a thorough review of updated evidence and expert opinions.